Anhui Anke Biotechnology (Group) Company., Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other companies in this sector in CHINA : Shenzhen Kangtai Biological Products Co Ltd (2019 sales of 1.94 billion Chinese Renmimbi [US$278.89 million] of which 100% was Biological products), Tianjin Ringpu Bio-Technology Co Ltd (1.47 billion Chinese Renmimbi [US$210.47 million] of which 57% was Veterinary Biological Products), and Beijing SL Pharmaceutical Co Ltd (2.03 billion Chinese Renmimbi [US$291.28 million] of which 99% was Pharmaceuticals Industry).

Sales Analysis. During the year ended December of 2019, sales at Anhui Anke Biotechnology (Group) Company., Limited were 1.71 billion Chinese Renmimbi (US$245.77 million). This is an increase of 17.2% versus 2018, when the company's sales were 1.46 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Anke Biotechnology (Group) Company., Limited (and since 2014, sales have increased a total of 216%). Sales of Technical Services saw an increase that was more than double the company's growth rate: sales were up 130.6% in 2019, from 57.16 million Chinese Renmimbi to 131.83 million Chinese Renmimbi.